{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:08:53Z","timestamp":1792958933905,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.kint.2015.10.002","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T01:52:39Z","timestamp":1451872359000},"page":"28-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":233,"title":["Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference"],"prefix":"10.1016","volume":"89","author":[{"given":"Iain C.","family":"Macdougall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Bircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio T.","family":"Obrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"B\u00e1r\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatole","family":"Besarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioav","family":"Cabantchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel L.M.","family":"de Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo A.J.M.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Hershko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Barton","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Rostoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Rottembourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzchak","family":"Slotki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Spinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tentori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Toblli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2015.10.002_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A\u00a0study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0272-6386(82)80059-0","article-title":"Gastrointestinal blood loss in patients with chronic renal failure","volume":"1","author":"Rosenblatt","year":"1982","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib3","first-page":"S218","article-title":"Gastrointestinal blood loss in patients undergoing maintenance dialysis","volume":"16","author":"Wizemann","year":"1983","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2015.10.002_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000074931","article-title":"Iron requirements in hemodialysis","volume":"22","author":"Sargent","year":"2004","journal-title":"Blood Purif"},{"key":"10.1016\/j.kint.2015.10.002_bib5","doi-asserted-by":"crossref","first-page":"c38","DOI":"10.1159\/000228074","article-title":"Increased iron requirement in hemodialysis patients on antiplatelet agents or warfarin","volume":"113","author":"Flint","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2015.10.002_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2215\/CJN.01810407","article-title":"Major bleeding in hemodialysis patients","volume":"3","author":"Holden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy","volume":"87","author":"Landefeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib8","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1681\/ASN.V7122654","article-title":"The evaluation of iron status in hemodialysis patients","volume":"7","author":"Fishbane","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0272-6386(95)90649-5","article-title":"Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era","volume":"26","author":"Kalantar-Zadeh","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2215\/CJN.04280609","article-title":"Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?","volume":"5","author":"Stancu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in\u00a0predicting response to intravenous iron in haemodialysis patients on\u00a0maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib12","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2015.10.002_bib13","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1093\/ndt\/gfq321","article-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents","volume":"25","author":"Tessitore","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib14","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/ndt\/gfn267","article-title":"Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?","volume":"23","author":"Swinkels","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients","volume":"12","author":"van der Putten","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2015.10.002_bib17","doi-asserted-by":"crossref","first-page":"e39783","DOI":"10.1371\/journal.pone.0039783","article-title":"Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents","volume":"7","author":"van der Weerd","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.10.002_bib18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications","volume":"57","author":"Kroot","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2015.10.002_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ajh.23289","article-title":"Second round robin for plasma hepcidin methods: first steps toward harmonization","volume":"87","author":"Kroot","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2015.10.002_bib20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.05990809","article-title":"Current status of the measurement of blood hepcidin levels in chronic kidney disease","volume":"5","author":"Macdougall","year":"2010","journal-title":"Clin\u00a0J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0016-5085(94)90237-2","article-title":"Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis","volume":"107","author":"Gualdi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2015.10.002_bib22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199909023411003","article-title":"Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene","volume":"341","author":"Pietrangelo","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2005-923315","article-title":"Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis","volume":"25","author":"Ramm","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.kint.2015.10.002_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.1977.tb00640.x","article-title":"Characterization of serum ferritin in iron overload: possible identity to natural apoferritin","volume":"36","author":"Arosio","year":"1977","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2015.10.002_bib28","doi-asserted-by":"crossref","first-page":"c7251","DOI":"10.1136\/bmj.c7251","article-title":"Diagnosis and management of hereditary haemochromatosis","volume":"342","author":"van Bokhoven","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2015.10.002_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05544.x","article-title":"Pathogenesis and management of iron toxicity in thalassemia","volume":"1202","author":"Hershko","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.kint.2015.10.002_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2015.10.002_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance","volume":"105","author":"St Pierre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.10.002_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2015.10.002_bib34","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","article-title":"Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"28","author":"Bailie","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib35","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2014090922","article-title":"Considerations and challenges in defining optimal iron utilization in hemodialysis","volume":"26","author":"Charytan","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib36","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1525-139X.2009.00590.x","article-title":"The role of oxidative stress in chronic kidney disease","volume":"22","author":"Massy","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2015.10.002_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/1354750X.2012.749302","article-title":"Clinical and research markers of oxidative stress in chronic kidney disease","volume":"18","author":"Tucker","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.kint.2015.10.002_bib39","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1681\/ASN.2007101084","article-title":"Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients","volume":"19","author":"Kuo","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/ajkd.2002.36334","article-title":"Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation","volume":"40","author":"Tovbin","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1592\/phco.27.3.343","article-title":"Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.kint.2015.10.002_bib42","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/ndt\/gfr711","article-title":"Effects of intravenous iron on mononuclear cells during the haemodialysis session","volume":"27","author":"Martin-Malo","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000334939","article-title":"Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion\/infiltration","volume":"35","author":"Kamanna","year":"2012","journal-title":"Am J Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.kint.2015.10.002_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","article-title":"Ferric saccharate induces oxygen radical stress and endothelial dysfunction in\u00a0vivo","volume":"32","author":"Rooyakkers","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2015.10.002_bib45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbagen.2008.06.005","article-title":"Iron in arterial plaque: modifiable risk factor for atherosclerosis","volume":"1790","author":"Sullivan","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2015.10.002_bib46","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.celrep.2013.11.009","article-title":"Testing the iron hypothesis in a mouse model of atherosclerosis","volume":"5","author":"Kautz","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.kint.2015.10.002_bib47","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1681\/ASN.2013080838","article-title":"Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD","volume":"25","author":"Kuo","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib48","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib49","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Drueke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2015.10.002_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease","volume":"46","author":"Reis","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.kint.2015.10.002_bib51","doi-asserted-by":"crossref","first-page":"e50295","DOI":"10.1371\/journal.pone.0050295","article-title":"Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients","volume":"7","author":"Kuo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.10.002_bib52","doi-asserted-by":"crossref","first-page":"e78930","DOI":"10.1371\/journal.pone.0078930","article-title":"Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients","volume":"8","author":"Kshirsagar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.10.002_bib53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease","volume":"366","author":"Fleming","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/hsz-2012-0217","article-title":"Beyond anemia: hepcidin, monocytes and inflammation","volume":"394","author":"Zhang","year":"2013","journal-title":"Biol Chem"},{"key":"10.1016\/j.kint.2015.10.002_bib55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1224577","article-title":"Hepcidin and the iron-infection axis","volume":"338","author":"Drakesmith","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.kint.2015.10.002_bib56","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2010-0864","article-title":"Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis","volume":"95","author":"Bachman","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2015.10.002_bib57","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/en.2011-2045","article-title":"17\u03b2-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site","volume":"153","author":"Yang","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2015.10.002_bib58","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2015.10.002_bib59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/ATVBAHA.110.214858","article-title":"Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations","volume":"31","author":"Valenti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2015.10.002_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/ATVBAHA.113.302381","article-title":"Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population","volume":"34","author":"Galesloot","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2015.10.002_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/ATVBAHA.111.240101","article-title":"Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis","volume":"32","author":"Saeed","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2015.10.002_bib62","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","article-title":"Hepcidin as well as TNF-alpha are significant predictors of arterial stiffness in patients on maintenance hemodialysis","volume":"26","author":"Kuragano","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib63","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","article-title":"Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients","volume":"28","author":"van der Weerd","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gft269","article-title":"Iron toxicity: relevance for dialysis patients","volume":"29","author":"Fishbane","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib65","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","article-title":"High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men","volume":"86","author":"Salonen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2015.10.002_bib66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.numecd.2010.01.003","article-title":"Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease","volume":"21","author":"Valenti","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2003.12.029","article-title":"A\u00a0low serum iron level is a predictor of poor outcome in hemodialysis patients","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.002_bib68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.V113539","article-title":"Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis","volume":"11","author":"Roob","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib69","first-page":"852","article-title":"Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress","volume":"21","author":"Swarnalatha","year":"2010","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.kint.2015.10.002_bib70","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10534-012-9562-6","article-title":"Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose","volume":"25","author":"Conner","year":"2012","journal-title":"Biometals"},{"key":"10.1016\/j.kint.2015.10.002_bib71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1681\/ASN.2013050545","article-title":"Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial","volume":"25","author":"Himmelfarb","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib72","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.kint.2015.10.002_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.kint.2015.10.002_bib74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbagen.2008.07.002","article-title":"Iron availability and infection","volume":"1790","author":"Weinberg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2015.10.002_bib75","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1462-5822.2010.01529.x","article-title":"The struggle for iron\u2014a metal at the host\u2013pathogen interface","volume":"12","author":"Nairz","year":"2010","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.kint.2015.10.002_bib76","first-page":"205","article-title":"Anaemia in inflammatory rheumatic diseases","volume":"9","author":"Weiss","year":"2013","journal-title":"Nat\u00a0Rev Rheumatol"},{"key":"10.1016\/j.kint.2015.10.002_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coi.2009.01.011","article-title":"Iron in innate immunity: starve the invaders","volume":"21","author":"Ganz","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2015.10.002_bib78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/sdi.12168","article-title":"Iron and infection in hemodialysis patients","volume":"27","author":"Ishida","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2015.10.002_bib79","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib80","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib81","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin","volume":"19","author":"Kapoian","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib82","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5414\/CNP66348","article-title":"Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients","volume":"66","author":"Sirken","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib83","doi-asserted-by":"crossref","first-page":"c128","DOI":"10.1159\/000110032","article-title":"Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors","volume":"107","author":"Diskin","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2015.10.002_bib84","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib85","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ndt\/gfu349","article-title":"Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study","volume":"30","author":"Tangri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib88","doi-asserted-by":"crossref","first-page":"e114144","DOI":"10.1371\/journal.pone.0114144","article-title":"Iron supplementation and mortality in incident dialysis patients: an observational study","volume":"9","author":"Zitt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.10.002_bib89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000358336","article-title":"Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis","volume":"39","author":"Susantitaphong","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib90","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","article-title":"Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials","volume":"347","author":"Litton","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2015.10.002_bib91","article-title":"Re: Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials","author":"Mu\u00f1oz","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2015.10.002_bib92","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/089686080102100310","article-title":"Experience with a large dose (500\u00a0mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients","volume":"21","author":"Prakash","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2015.10.002_bib93","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A\u00a0randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.002_bib94","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/psb.927","article-title":"Oral iron: properties and current place in the treatment of anaemia","volume":"23","author":"Chaplin","year":"2012","journal-title":"Prescriber"},{"key":"10.1016\/j.kint.2015.10.002_bib96","first-page":"305","article-title":"Anaphylaxis to oral iron salts. Desensitization protocol for tolerance induction","volume":"18","author":"de Barrio","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.kint.2015.10.002_bib97","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI100478","article-title":"Quantitative aspects of iron deficiency in hypochromic anemia: the parenteral administration of iron","volume":"11","author":"Heath","year":"1932","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.002_bib98","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ajh.23534","article-title":"Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min","volume":"88","author":"Auerbach","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2015.10.002_bib99","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1185\/03007990903512461","article-title":"Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?","volume":"26","author":"Macdougall","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.kint.2015.10.002_bib100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ndt\/gft251","article-title":"Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial","volume":"29","author":"Onken","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib101","first-page":"589","article-title":"Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease","volume":"24","author":"Wikstrom","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1778-428X.2007.00050.x","article-title":"Tolerability and efficacy of parenteral iron therapy in hemodialysis patients","volume":"9","author":"Moniem","year":"2007","journal-title":"Trans Alt Trans Med"},{"key":"10.1016\/j.kint.2015.10.002_bib103","unstructured":"FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). US Food and Drug Administration, Drug Safety Communications. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM440336.pdf. Accessed 18 May\u00a02015."},{"key":"10.1016\/j.kint.2015.10.002_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv277","article-title":"Ferric pyrophosphate citrate (Triferic) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients","author":"Fishbane","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","article-title":"Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD","volume":"9","author":"Yokoyama","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib106","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1093\/ndt\/gfs372","article-title":"A\u00a0randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial","volume":"27","author":"Barraclough","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib107","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(07)60689-8","article-title":"Clinical update: intravenous iron for anaemia","volume":"369","author":"Auerbach","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2015.10.002_bib108","doi-asserted-by":"crossref","first-page":"c63","DOI":"10.1159\/000076401","article-title":"Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products","volume":"96","author":"Charytan","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2015.10.002_bib109","unstructured":"EU Clinical Trials Register. Available at: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2013-002267-25\/GB. Accessed 18 May\u00a02015."},{"key":"10.1016\/j.kint.2015.10.002_bib110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib111","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/ATVBAHA.112.246108","article-title":"Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2015.10.002_bib112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000315953","article-title":"Anaphylaxis: acute treatment and management","volume":"95","author":"Ring","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.kint.2015.10.002_bib113","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/cs0380191","article-title":"Iron absorption in chronic renal disease","volume":"38","author":"Eschbach","year":"1970","journal-title":"Clin Sci"},{"key":"10.1016\/j.kint.2015.10.002_bib114","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/ndt\/13.10.2578","article-title":"The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/13.1.82","article-title":"Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib116","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-6386(96)90463-1","article-title":"The safety of intravenous iron dextran in hemodialysis patients","volume":"28","author":"Fishbane","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1016\/j.kint.2015.10.002_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2362.2002.0320s1042.x","article-title":"Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients","volume":"32","author":"Esposito","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2015.10.002_bib118","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/gfg579","article-title":"Labile iron in parenteral iron formulations: a quantitative and comparative study","volume":"19","author":"Van Wyck","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib119","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1542-4758.2011.00550.x","article-title":"Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients","volume":"15","author":"Atalay","year":"2011","journal-title":"Hemodial Int"},{"key":"10.1016\/j.kint.2015.10.002_bib120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9343(00)00396-X","article-title":"Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation","volume":"109","author":"Barton","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib121","unstructured":"European Medicines Agency. Procedure no. EMEA\/H\/A-31\/1322, September\u00a02013."},{"key":"10.1016\/j.kint.2015.10.002_bib122","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.002_bib123","first-page":"233","article-title":"Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study","volume":"175","author":"Viethen","year":"2014","journal-title":"Int\u00a0J\u00a0Cardiol"},{"key":"10.1016\/j.kint.2015.10.002_bib124","first-page":"CD007834","article-title":"Iron for restless legs syndrome","volume":"5","author":"Trotti","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2015.10.002_bib125","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.sleep.2014.08.012","article-title":"Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)","volume":"15","author":"Mehmood","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.kint.2015.10.002_bib126","doi-asserted-by":"crossref","first-page":"e94217","DOI":"10.1371\/journal.pone.0094217","article-title":"Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women\u2014PREFER a randomized, placebo-controlled study","volume":"9","author":"Favrat","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.10.002_bib127","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2011-04-346304","article-title":"Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration","volume":"118","author":"Krayenbuehl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.10.002_bib128","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/ndt\/gfs322","article-title":"Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease","volume":"27","author":"Niihata","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.002_bib129","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10534-011-9409-6","article-title":"Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose","volume":"24","author":"Pai","year":"2011","journal-title":"Biometals"},{"issue":"suppl 2","key":"10.1016\/j.kint.2015.10.002_bib130","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.002_bib131","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T14:52:24Z","timestamp":1654008744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0085253815000034"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2015.10.002","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}